Comparison of the safety of remimazolam and propofol during general anesthesia in elderly patients: systematic review and meta-analysis
BackgroundRemimazolam is a novel sedative drug approved for procedural sedation and general anesthesia. Clinical trials have already explored its use in elderly patients for general anesthesia. For elderly patients with declining physical and physiological function, anesthesia safety is crucial. Mos...
Saved in:
Main Authors: | Xianchun Liu, Longyi Zhang, Li Zhao, Xuelei Zhou, Wei Mao, Linlin Chen, Hongyu Zhu, Ying Xie, Linji Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1409495/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy and safety of remimazolam besylate, ciprofol, and propofol during hysteroscopy
by: Weifeng Shan, et al.
Published: (2025-01-01) -
Comparison of intraoperative neurophysiological monitoring between propofol and remimazolam during total intravenous anesthesia in the cervical spine surgery: a prospective, double-blind, randomized controlled trial
by: Myoung Hwa Kim, et al.
Published: (2025-02-01) -
Comparing the safety and efficacy of remimazolam-based total intravenous anesthesia versus volatile agent-based anesthesia: a meta-analysis of randomized controlled trials
by: Ji-In Park, et al.
Published: (2025-02-01) -
Remimazolam for the prevention of emergence agitation in adults following nasal surgery under general anesthesia: a prospective randomized clinical controlled trial
by: Yanfei Lu, et al.
Published: (2025-01-01) -
Procedural sedative effect of remimazolam in ICU patients on invasive mechanical ventilation: a randomised, prospective study
by: Youli Tian, et al.
Published: (2025-01-01)